Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Emergent BioSolutions Inc. EBS

Full chart Compare
Set alert

Price alert · EBS

All alert types
5.85 USD -0.05 (-0.85%)

At closeNov 6, 2026, 4:00 AM EST

5.72 -0.13 -2.22%

Pre-market · Nov 6, 4:00 AM ET

5.80 Day range 6.04
4.36 52-week range 14.06
YTD
-52.67%
1 year
-43.04%

Financial health

Altman Z-Score

0.25 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E 12.6×
FY 2016: 25.5×FY 2017: 23.5×FY 2018: 47.4×FY 2019: 50.9×FY 2020: 15.5×FY 2021: 10.6×FY 2022: -2.8×FY 2023: -0.2×FY 2024: -2.7×FY 2025: 12.6×
FY 2016 5y median -0.2× FY 2025
P/S 0.9×
FY 2016: 2.7×FY 2017: 3.5×FY 2018: 3.8×FY 2019: 2.5×FY 2020: 3.0×FY 2021: 1.3×FY 2022: 0.5×FY 2023: 0.1×FY 2024: 0.5×FY 2025: 0.9×
FY 2016 5y median 0.5× FY 2025
P/B 1.3×
FY 2016: 2.2×FY 2017: 2.1×FY 2018: 2.9×FY 2019: 2.6×FY 2020: 3.3×FY 2021: 1.4×FY 2022: 0.4×FY 2023: 0.2×FY 2024: 1.0×FY 2025: 1.3×
FY 2016 5y median 1.0× FY 2025
P/FCF 4.2×
FY 2016: -58.0×FY 2017: 12.7×FY 2018: -98.0×FY 2019: 27.5×FY 2020: 12.0×FY 2021: 24.2×FY 2022: -3.9×FY 2023: -0.5×FY 2024: 14.2×FY 2025: 4.2×
FY 2016 5y median 4.2× FY 2025
EV/EBITDA 4.3×
FY 2016: 9.9×FY 2017: 10.2×FY 2018: 23.5×FY 2019: 13.2×FY 2020: 8.2×FY 2021: 5.1×FY 2022: 40.5×FY 2023: -20.3×FY 2024: 19.1×FY 2025: 4.3×
FY 2016 5y median 5.1× FY 2025
EV/Sales 1.4×
FY 2016: 2.7×FY 2017: 3.2×FY 2018: 4.7×FY 2019: 3.1×FY 2020: 3.2×FY 2021: 1.5×FY 2022: 1.2×FY 2023: 0.8×FY 2024: 1.0×FY 2025: 1.4×
FY 2016 5y median 1.2× FY 2025
FCF Yield 23.7%
FY 2016: -1.7%FY 2017: 7.9%FY 2018: -1.0%FY 2019: 3.6%FY 2020: 8.4%FY 2021: 4.1%FY 2022: -25.3%FY 2023: -209.9%FY 2024: 7.1%FY 2025: 23.7%
FY 2016 5y median 4.1% FY 2025

Profitability

Gross Margin 47.2%
FY 2016: 50.1%FY 2017: 50.6%FY 2018: 41.0%FY 2019: 43.7%FY 2020: 54.7%FY 2021: 44.7%FY 2022: 42.3%FY 2023: 34.3%FY 2024: 36.0%FY 2025: 47.2%
FY 2016 5y median 42.3% FY 2025
Operating Margin 14.8%
FY 2016: 21.6%FY 2017: 22.2%FY 2018: 11.5%FY 2019: 10.3%FY 2020: 27.8%FY 2021: 19.2%FY 2022: -15.2%FY 2023: -69.2%FY 2024: -10.4%FY 2025: 14.8%
FY 2016 5y median -10.4% FY 2025
Net Margin 7.1%
FY 2016: 10.6%FY 2017: 14.7%FY 2018: 8.0%FY 2019: 4.9%FY 2020: 19.4%FY 2021: 12.4%FY 2022: -18.9%FY 2023: -72.5%FY 2024: -18.3%FY 2025: 7.1%
FY 2016 5y median -18.3% FY 2025
ROE 10.1%
FY 2016: 8.7%FY 2017: 9.1%FY 2018: 6.2%FY 2019: 5.0%FY 2020: 21.1%FY 2021: 13.6%FY 2022: -15.2%FY 2023: -117.1%FY 2024: -39.5%FY 2025: 10.1%
FY 2016 5y median -15.2% FY 2025
ROIC 5.9%
FY 2016: 7.5%FY 2017: 8.9%FY 2018: 3.4%FY 2019: 3.8%FY 2020: 12.8%FY 2021: 9.4%FY 2022: -5.7%FY 2023: -45.8%FY 2024: -8.8%FY 2025: 5.9%
FY 2016 5y median -5.7% FY 2025
ROA 4.0%
FY 2016: 5.3%FY 2017: 7.7%FY 2018: 2.8%FY 2019: 2.3%FY 2020: 10.6%FY 2021: 7.4%FY 2022: -6.7%FY 2023: -41.7%FY 2024: -13.7%FY 2025: 4.0%
FY 2016 5y median -6.7% FY 2025

Growth (YoY)

Revenue -28.8%
FY 2016: -0.1%FY 2017: 14.8%FY 2018: 39.5%FY 2019: 41.4%FY 2020: 42.6%FY 2021: 12.4%FY 2022: -37.0%FY 2023: -6.1%FY 2024: -0.5%FY 2025: -28.8%
FY 2016 FY 2025
Operating Income 201.4%
FY 2016: -25.4%FY 2017: 17.8%FY 2018: -27.8%FY 2019: 27.1%FY 2020: 284.3%FY 2021: -22.1%FY 2022: -149.8%FY 2023: -327.3%FY 2024: 85.0%FY 2025: 201.4%
FY 2016 FY 2025
EPS (diluted) 125.8%
FY 2016: -19.9%FY 2017: 51.3%FY 2018: -28.7%FY 2019: -14.8%FY 2020: 445.2%FY 2021: -28.4%FY 2022: -203.9%FY 2023: -251.9%FY 2024: 75.8%FY 2025: 125.8%
FY 2016 FY 2025
Free Cash Flow 338.0%
FY 2016: -6350.4%FY 2017: 773.3%FY 2018: -119.8%FY 2019: 433.7%FY 2020: 290.7%FY 2021: -75.7%FY 2022: -256.0%FY 2023: -72.0%FY 2024: 113.9%FY 2025: 338.0%
FY 2016 FY 2025

Financial Health

Current Ratio 5.0×
FY 2016: 4.8×FY 2017: 4.9×FY 2018: 3.1×FY 2019: 3.2×FY 2020: 3.1×FY 2021: 3.4×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 3.7×FY 2025: 5.0×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 2.4×
FY 2016: 4.1×FY 2017: 3.4×FY 2018: 2.1×FY 2019: 2.1×FY 2020: 2.3×FY 2021: 2.5×FY 2022: 0.7×FY 2023: 0.5×FY 2024: 1.8×FY 2025: 2.4×
FY 2016 5y median 1.8× FY 2025
Debt / Equity 1.1×
FY 2016: 0.4×FY 2017: 0.0×FY 2018: 0.8×FY 2019: 0.8×FY 2020: 0.6×FY 2021: 0.5×FY 2022: 1.0×FY 2023: 1.3×FY 2024: 1.4×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Net Debt / EBITDA 1.5×
FY 2016: -0.0×FY 2017: -0.9×FY 2018: 4.4×FY 2019: 2.6×FY 2020: 0.5×FY 2021: 0.6×FY 2022: 23.1×FY 2023: -17.4×FY 2024: 10.2×FY 2025: 1.5×
FY 2016 5y median 1.5× FY 2025
Interest Coverage 1.9×
FY 2016: 13.9×FY 2017: 18.9×FY 2018: 9.1×FY 2019: 3.0×FY 2020: 14.0×FY 2021: 9.9×FY 2022: -4.6×FY 2023: -8.3×FY 2024: -1.5×FY 2025: 1.9×
FY 2016 5y median -1.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31